ID   NLGN3_RAT               Reviewed;         848 AA.
AC   Q62889;
DT   23-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 167.
DE   RecName: Full=Neuroligin-3;
DE   AltName: Full=Gliotactin homolog;
DE   Flags: Precursor;
GN   Name=Nlgn3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), BLOCKAGE OF
RP   N-TERMINUS, TISSUE SPECIFICITY, AND INTERACTION WITH NEUREXIN 1-BETA;
RP   NEUREXIN 2-BETA AND NEUREXIN 3-BETA.
RC   TISSUE=Forebrain;
RX   PubMed=8576240; DOI=10.1074/jbc.271.5.2676;
RA   Ichtchenko K., Nguyen T., Suedhof T.C.;
RT   "Structures, alternative splicing, and neurexin binding of multiple
RT   neuroligins.";
RL   J. Biol. Chem. 271:2676-2682(1996).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=11329178; DOI=10.1002/glia.1050;
RA   Gilbert M., Smith J., Roskams A.J., Auld V.J.;
RT   "Neuroligin 3 is a vertebrate gliotactin expressed in the olfactory
RT   ensheathing glia, a growth-promoting class of macroglia.";
RL   Glia 34:151-164(2001).
RN   [3]
RP   MUTAGENESIS OF ARG-451, SUBCELLULAR LOCATION, INTERACTION WITH NRXN1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15152050; DOI=10.1523/jneurosci.0468-04.2004;
RA   Comoletti D., De Jaco A., Jennings L.L., Flynn R.E., Gaietta G.,
RA   Tsigelny I., Ellisman M.H., Taylor P.;
RT   "The Arg451Cys-neuroligin-3 mutation associated with autism reveals a
RT   defect in protein processing.";
RL   J. Neurosci. 24:4889-4893(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=16982420; DOI=10.1016/j.neuron.2006.09.003;
RA   Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M.,
RA   Gottmann K., Zhang W., Sudhof T.C., Brose N.;
RT   "Neuroligins determine synapse maturation and function.";
RL   Neuron 51:741-754(2006).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17897391; DOI=10.1111/j.1460-9568.2007.05842.x;
RA   Budreck E.C., Scheiffele P.;
RT   "Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic
RT   synapses.";
RL   Eur. J. Neurosci. 26:1738-1748(2007).
RN   [6]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=18755801; DOI=10.1210/en.2008-0274;
RA   Suckow A.T., Comoletti D., Waldrop M.A., Mosedale M., Egodage S.,
RA   Taylor P., Chessler S.D.;
RT   "Expression of neurexin, neuroligin, and their cytoplasmic binding partners
RT   in the pancreatic beta-cells and the involvement of neuroligin in insulin
RT   secretion.";
RL   Endocrinology 149:6006-6017(2008).
RN   [7]
RP   INTERACTION WITH NRXN1.
RX   PubMed=20624592; DOI=10.1016/j.neuron.2010.06.001;
RA   Koehnke J., Katsamba P.S., Ahlsen G., Bahna F., Vendome J., Honig B.,
RA   Shapiro L., Jin X.;
RT   "Splice form dependence of beta-neurexin/neuroligin binding interactions.";
RL   Neuron 67:61-74(2010).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19914352; DOI=10.1016/j.neuroscience.2009.11.016;
RA   Levinson J.N., Li R., Kang R., Moukhles H., El-Husseini A., Bamji S.X.;
RT   "Postsynaptic scaffolding molecules modulate the localization of
RT   neuroligins.";
RL   Neuroscience 165:782-793(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-745, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cell surface protein involved in cell-cell-interactions via
CC       its interactions with neurexin family members. Plays a role in synapse
CC       function and synaptic signal transmission, and probably mediates its
CC       effects by recruiting and clustering other synaptic proteins. May
CC       promote the initial formation of synapses, but is not essential for
CC       this. May also play a role in glia-glia or glia-neuron interactions in
CC       the developing peripheral nervous system.
CC       {ECO:0000269|PubMed:17897391}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with NLGN1 and NLGN2 (By
CC       similarity). Interacts with neurexins NRXN1, NRXN2 and NRXN3
CC       (PubMed:15152050, PubMed:20624592, PubMed:8576240). Interaction with
CC       neurexins is mediated by heparan sulfate glycan modification on
CC       neurexin (By similarity). Interacts (via its C-terminus) with DLG4/PSD-
CC       95 (via PDZ domain 3) (By similarity). {ECO:0000250|UniProtKB:Q8BYM5,
CC       ECO:0000250|UniProtKB:Q9NZ94, ECO:0000269|PubMed:15152050,
CC       ECO:0000269|PubMed:20624592, ECO:0000269|PubMed:8576240}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Synapse. Note=Detected at both glutamatergic and GABAergic
CC       synapses.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q62889-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62889-2; Sequence=VSP_007535, VSP_007536;
CC       Name=3;
CC         IsoId=Q62889-3; Sequence=VSP_007536;
CC       Name=4;
CC         IsoId=Q62889-4; Sequence=VSP_007535;
CC   -!- TISSUE SPECIFICITY: Detected in brain and on hippocampus neurons,
CC       especially at excitatory synapses. Detected in retina (at protein
CC       level). Expressed in brain, spinal cord and dorsal root ganglion.
CC       {ECO:0000269|PubMed:11329178, ECO:0000269|PubMed:16982420,
CC       ECO:0000269|PubMed:17897391, ECO:0000269|PubMed:18755801,
CC       ECO:0000269|PubMed:19914352, ECO:0000269|PubMed:8576240}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U41663; AAA97871.1; -; mRNA.
DR   RefSeq; NP_599163.2; NM_134336.2.
DR   AlphaFoldDB; Q62889; -.
DR   SMR; Q62889; -.
DR   BioGRID; 251173; 2.
DR   IntAct; Q62889; 1.
DR   MINT; Q62889; -.
DR   STRING; 10116.ENSRNOP00000005077; -.
DR   ESTHER; ratno-3neur; Neuroligin.
DR   MEROPS; S09.987; -.
DR   GlyCosmos; Q62889; 2 sites, No reported glycans.
DR   GlyGen; Q62889; 2 sites.
DR   iPTMnet; Q62889; -.
DR   PhosphoSitePlus; Q62889; -.
DR   PaxDb; 10116-ENSRNOP00000005077; -.
DR   ABCD; Q62889; 1 sequenced antibody.
DR   GeneID; 171297; -.
DR   KEGG; rno:171297; -.
DR   UCSC; RGD:621119; rat. [Q62889-1]
DR   AGR; RGD:621119; -.
DR   CTD; 54413; -.
DR   RGD; 621119; Nlgn3.
DR   eggNOG; KOG1516; Eukaryota.
DR   InParanoid; Q62889; -.
DR   OrthoDB; 4386at2759; -.
DR   PhylomeDB; Q62889; -.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   PRO; PR:Q62889; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:BHF-UCL.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0042043; F:neurexin family protein binding; IPI:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; IDA:BHF-UCL.
DR   GO; GO:0030534; P:adult behavior; ISO:RGD.
DR   GO; GO:0048675; P:axon extension; IMP:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0042745; P:circadian sleep/wake cycle; IMP:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; IDA:BHF-UCL.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISS:BHF-UCL.
DR   GO; GO:0061002; P:negative regulation of dendritic spine morphogenesis; ISO:RGD.
DR   GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:1900451; P:positive regulation of glutamate receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; IDA:RGD.
DR   GO; GO:1902474; P:positive regulation of protein localization to synapse; IMP:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IDA:BHF-UCL.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL.
DR   GO; GO:2000809; P:positive regulation of synaptic vesicle clustering; ISO:RGD.
DR   GO; GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0098698; P:postsynaptic specialization assembly; IDA:SynGO.
DR   GO; GO:0060134; P:prepulse inhibition; IMP:RGD.
DR   GO; GO:0097105; P:presynaptic membrane assembly; IDA:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:BHF-UCL.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; ISS:BHF-UCL.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:BHF-UCL.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; ISS:BHF-UCL.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; ISS:BHF-UCL.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; ISS:BHF-UCL.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL.
DR   GO; GO:2000331; P:regulation of terminal button organization; ISS:BHF-UCL.
DR   GO; GO:0060024; P:rhythmic synaptic transmission; IMP:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; ISS:BHF-UCL.
DR   GO; GO:0007416; P:synapse assembly; IDA:BHF-UCL.
DR   GO; GO:0050808; P:synapse organization; IDA:MGI.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   GO; GO:0071625; P:vocalization behavior; ISO:RGD.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR051093; Neuroligin/BSAL.
DR   InterPro; IPR000460; Nlgn.
DR   PANTHER; PTHR43903; NEUROLIGIN; 1.
DR   PANTHER; PTHR43903:SF4; NEUROLIGIN-3; 1.
DR   Pfam; PF00135; COesterase; 1.
DR   PRINTS; PR01090; NEUROLIGIN.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Disulfide bond;
KW   Glycoprotein; Membrane; Phosphoprotein; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..37
FT                   /evidence="ECO:0000255"
FT   CHAIN           38..848
FT                   /note="Neuroligin-3"
FT                   /id="PRO_0000008647"
FT   TOPO_DOM        38..709
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        710..730
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        731..848
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          169..195
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          645..691
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        645..687
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         745
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         792
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BYM5"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        545
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        106..141
FT                   /evidence="ECO:0000250"
FT   DISULFID        340..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        510..544
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         153..172
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:8576240"
FT                   /id="VSP_007535"
FT   VAR_SEQ         173..192
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8576240"
FT                   /id="VSP_007536"
FT   MUTAGEN         451
FT                   /note="R->C: Impaired cell surface expression, and reduced
FT                   interaction with NRXN1."
FT                   /evidence="ECO:0000269|PubMed:15152050"
SQ   SEQUENCE   848 AA;  93888 MW;  7520653B3253E750 CRC64;
     MWLQLGLPSL SLSPTPTVGR SLCLILWFLS LVLRASTQAP APTVNTHFGK LRGARVPLPS
     EILGPVDQYL GVPYAAPPIG EKRFLPPEPP PSWSGIRNAT HFPPVCPQNI HTAVPEVMLP
     VWFTANLDIV ATYIQEPNED CLYLNVYVPT EDVKRISKEC ARKPNKKICR KGGSGAKKQG
     EDLADNDGDE DEDIRDSGAK PVMVYIHGGS YMEGTGNMID GSVLASYGNV IVITLNYRVG
     VLGFLSTGDQ AAKGNYGLLD QIQALRWVSE NIAFFGGDPR RITVFGSGIG ASCVSLLTLS
     HHSEGLFQRA IIQSGSALSS WAVNYQPVKY TSLLADKVGC NVLDTVDMVD CLRQKSAKEL
     VEQDIQPARY HVAFGPVIDG DVIPDDPEIL MEQGEFLNYD IMLGVNQGEG LKFVEGVVDP
     EDGVSGTDFD YSVSNFVDNL YGYPEGKDTL RETIKFMYTD WADRDNPETR RKTLVALFTD
     HQWVEPSVVT ADLHARYGSP TYFYAFYHHC QSLMKPAWSD AAHGDEVPYV FGVPMVGPTD
     LFPCNFSKND VMLSAVVMTY WTNFAKTGDP NKPVPQDTKF IHTKANRFEE VAWSKYNPRD
     QLYLHIGLKP RVRDHYRATK VAFWKHLVPH LYNLHDMFHY TSTTTKVPPP DTTHSSHITR
     RPNGKTWSTK RPAISPAYSN ENAPGSWNGD QDAGPLLVEN PRDYSTELSV TIAVGASLLF
     LNVLAFAALY YRKDKRRQEP LRQPSPQRGT GAPELGTAPE EELAALQLGP THHECEAGPP
     HDTLRLTALP DYTLTLRRSP DDIPLMTPNT ITMIPNSLVG LQTLHPYNTF AAGFNSTGLP
     NSHSTTRV
//
